Market-distorting price controls are bad enough. But when what’s being controlled are medicines that save and enhance lives, they’re far worse. A true shame, then, that a White House supposedly ...

President Donald Trump is right that Americans pay too much for many pharmaceuticals. However, his legally unenforceable ...

Biosimilars, too, are expected to gain ground as healthcare systems worldwide look for cost-effective alternatives to ...

New Delhi [India]: Generic drug companies in India are not expected to be affected by US President Donald Trump's new order ...

A sweeping US executive order by President Donald Trump to slash prescription drug prices to match international levels is ...

A report suggests Indian generic drug companies may not be affected by US President Donald Trump's order. The order aims to ...

The report noted that many specifics of the executive order remain unclear. Authorities have not disclosed which drugs, ...

President Donald Trump incorrectly placed the blame for high prescription drug prices in the U.S. on foreign nations, making ...

Emphasizes that the United States aims to provide access to prescription drugs at lower costs for US patients and taxpayers, ...

In signing an executive order aimed at reducing U.S. drug prices, President Donald Trump said some prices would be cut in ...

Seoul: Celltrion, a leading South Korean biopharmaceutical company, on Thursday said its business will remain largely ...

The EO states that while American citizens represent only 5% of the global population, they fund around 75% of global ...